Test
The CEF peptide pool stimulates CD8+ T cells to produce preferentially IFN-γ and is recommended as a positive control in IFN-γ ELISpot and FluoroSpot assays using human PBMC. The CEF peptide pool consists of 23 MHC class I-restricted viral peptides from human CMV, EBV and influenza virus. It has been shown to induce IFN-γ responses in almost 90% of all Caucasians.
NC1925864 CEFTA PEPTIDE POOL HMN CD4T
The CMV (pp65) Peptide Pool is a lyophilized mixture of 138 peptides from the 65 kDa phosphoprotein (pp65) of human cytomegalovirus (CMV; strain AD169). pp65 has been shown to counteract the induction of interferon response by preventing the activation of interferon response factor 3 (IRF-3). pp65 is also important in inducing transcription of viral immediate-early promoter. The pool consists of 15-mer peptides with 11-amino-acid overlaps that cover amino acids 1 - 561 on pp65.
NC1808774 CEF EXT PEPTIDE POOL HMN CD8T
NC2954145 HPV16/E7 ANTIBODY 100 UG
SARS-CoV-2 spike protein Delta/B.1.617.2 variant mutation peptide pool for immune cell activation
Epstein-Barr virus GP350/340 peptide pool for immune cell activation
MIM™-12 Phage Display Peptide Library Kit
MHC CLass II Peptide Pool Plus
NC2821816 TEST IE
CEF Control Peptide Pool, (1 mg) This product contains 0.03 mg (net) of the 32 CEF peptides for a total of 1 mg in one vial. Used in the stimulation of IFNy release from CD8+ T cells in individuals with defined HLA types, these epitopes are useful in applications such as ELISPOT, intracellular cytokine and CTL assays.
NC2733275 HA B/PHUKET/3073/2013 0.1 MG
Epstein-Barr virus EBV control peptide pool for immune cell activation
SARS-CoV-2 spike protein Delta/B.1.617.2 variant wild-type reference peptide pool for immune cell activation
SARS-CoV-2 spike protein Omicron/B.1.1.529 variant mutation peptide pool for immune cell activation